In conclusion, drawing on insights from genetic and chemical screens, these results suggest that G9a is an actionable dependency in T-ALL and provide further support for the anti-proliferative effects of suppressing G9a HMTase activity in T-ALL. This evidence concerns the gene EHMT2 and acute lymphoblastic leukemia.